Botox for Chronic Migraine Sydney | PBS Treatment | Dr Ron Granot

Botox for Chronic Migraine in Sydney

PBS-listed treatment by a neurologist accredited in the PREEMPT protocol. Trained at Prince of Wales Hospital — Sydney's leading headache centre.

Book a Consultation

Botox for Migraine — The Basics

Botulinum toxin type A (Botox) is a preventative treatment for chronic migraine — not an acute treatment. It works by blocking the release of pain-signalling chemicals at peripheral nerve endings in the scalp and neck, reducing the sensitisation that drives migraine. It has been on the Pharmaceutical Benefits Scheme (PBS) in Australia for chronic migraine since 2014.

Dr Ron Granot is an accredited Botox injector for chronic migraine using the standardised PREEMPT protocol. He trained at Prince of Wales Hospital — Sydney's leading headache and neurology training centre — and has administered many hundreds of Botox cycles for chronic migraine.

PBS Eligibility for Chronic Migraine Botox

Botox is PBS-subsidised for chronic migraine only when specific criteria are met. The criteria define a tightly defined patient group with treatment-resistant chronic migraine.

Patient must meet ALL of the following

  • Chronic migraine — 15 or more headache days per month, with at least 8 being migraine, for 3 months or more
  • Adequate trials of at least 3 oral preventatives from different classes (e.g. propranolol, topiramate, amitriptyline, candesartan, sodium valproate) — each at adequate dose and duration, discontinued for inefficacy or intolerance
  • Treatment prescribed by a neurologist or pain medicine specialist (Dr Granot meets this)
  • Not concurrently receiving a PBS-subsidised CGRP monoclonal antibody for migraine prevention

Reassessment — Authority approval is granted for 2 cycles initially; continuation requires demonstrating ≥50% reduction in headache days.

What to Expect at Your Botox Appointment

1

Pre-treatment consultation

Review of your headache diary, prior preventative trials, and confirmation of PBS eligibility. A baseline assessment is essential — we cannot demonstrate response without documented baseline headache days. If you don't have a recent diary, we'll start one before treatment.

2

PBS authority application

Dr Granot submits the PBS authority application on your behalf. Approval typically comes through within days. You collect the Botox vial from your pharmacy (or it is provided in-rooms depending on supply).

3

The injection procedure

31 small intramuscular injections of approximately 155 units of onabotulinumtoxinA into standardised PREEMPT sites: forehead (4), temples (8), back of head (6), neck (6), and upper trapezius (8). The actual injecting takes about 8 minutes. The procedure feels like a series of small pinpricks; most patients finish saying it was nowhere near as bad as what they had expected.

"Follow the pain" technique: beyond the standard PREEMPT sites, additional injections are added at sites of localised pain or trigger points. In Dr Granot's experience this can improve response rate.

4

After the injection

You can drive home and resume normal activities the same day. Avoid lying flat for 4 hours and avoid massaging the injection sites for 24 hours. Mild neck stiffness for a few days is the most common after-effect.

5

Follow-up & response assessment

The next cycle is at 12 weeks. Response is formally assessed after cycle 2 using your continuing headache diary. PBS continuation requires ≥50% reduction in headache days from baseline. Most responders notice benefit by cycle 2; a minority respond after cycle 1 or take 3 cycles.

What Response Looks Like — Realistic Expectations

In the original PREEMPT clinical trials, 40–50% of patients achieved >50% reduction in headache days per month with Botox. In post-trial data presented at the Congress of European Neurology (2017), 65% of first-time Botox patients were satisfied or very satisfied with their treatment. Comparable response rates to oral preventatives such as topiramate, valproate and amitriptyline — but with the convenience of 12-weekly dosing and few systemic side effects.

Practical framing: a meaningful proportion of patients see substantial benefit; a smaller proportion see partial benefit; and some are non-responders despite optimal technique. PBS continuation requires demonstrated ≥50% reduction in headache days after cycle 2. Honest framing of these numbers up-front is part of how we discuss treatment.

What Botox is good at

  • Reducing total headache days per month
  • Reducing severity of headaches that do occur
  • Reducing dependence on acute medications (helps medication-overuse cycles)
  • Convenient 12-weekly dosing — no daily tablets to remember
  • Few systemic side effects compared with oral preventatives

What Botox is not

  • Not an acute treatment — doesn't stop a migraine in progress
  • Not effective for episodic migraine (<15 headache days/month) under PBS criteria
  • Not a cure — discontinuing treatment generally returns headaches to baseline
  • Not universally effective — about 50% see meaningful benefit by cycle 2
  • Not first-line — used after oral preventatives have failed

Botox vs CGRP — When to Choose Which

Both Botox and CGRP monoclonal antibodies are PBS-listed preventative options for migraine. They work differently and PBS rules currently prevent claiming both simultaneously. The choice depends on individual factors.

FactorBotox (PREEMPT)CGRP mAbs (Emgality, Aimovig, Vyepti)
PBS indicationChronic migraine — ≥15 headache days/month with ≥8 migraine daysChronic migraine — ≥8 headache days/month (3 agents PBS; Aimovig private only)
DosingEvery 12 weeks, in-rooms procedureMonthly (Emgality, Aimovig) or 3-monthly IV (Vyepti) — usually self-injection at home
Time to responseOften after cycle 2 (24 weeks)Often within 4–8 weeks
Onset side effectsNeck stiffness, mild brow heavinessInjection-site reactions, mild constipation, rare allergic reactions
PregnancyRelative contraindicationNot recommended (long half-life, washout required before conception)
Concurrent useNot concurrently PBS-subsidised. Sequential trials permitted under authority.

Read about CGRP therapies →

Frequently Asked Questions

Who is eligible for PBS-subsidised Botox for chronic migraine? +
PBS criteria require chronic migraine (≥15 headache days per month with at least 8 being migraine, for 3+ months), failed adequate trials of at least three oral preventative medications from different classes, treatment prescribed by a neurologist or pain medicine specialist, and not currently receiving CGRP therapy. Authority approval is required and is renewed every 6 months based on demonstrated response.
How does Botox work for migraine? +
Botox blocks the release of pain-signalling chemicals (including CGRP and substance P) from nerve endings in the head and neck. It prevents nerve sensitisation rather than treating acute attacks. Most patients notice benefit by cycle 2 (week 24); some respond after cycle 1.
How is the treatment given? +
Using the PREEMPT protocol — 31 small intramuscular injections of approximately 155 units of onabotulinumtoxinA into standardised sites across the forehead, temples, back of the head, neck and upper shoulders. The procedure takes about 15–20 minutes in the consulting room. Most patients tolerate it well; ice may be used to numb the injection sites if desired.
How often is Botox given? +
Every 12 weeks. PBS guidelines require at least two cycles before assessing response. If headache day reduction is at least 50% by the end of cycle 2, treatment continues; if not, it's discontinued.
What are the side effects? +
The most common side effect is mild neck pain or stiffness for a few days after injection. Other possible effects include injection-site soreness, transient brow heaviness, and very rarely mild ptosis (eyelid droop) lasting up to a few weeks. Serious side effects are uncommon when the procedure is performed by an experienced injector using the PREEMPT protocol.
Can I combine Botox with oral preventatives or CGRP medications? +
Botox can be combined with oral preventatives. PBS does not permit concurrent CGRP and Botox subsidy — patients must choose one. Switching between them is permitted if one is ineffective; the criteria and washout periods are managed through the PBS authority process.
How much does it cost? +
When PBS criteria are met, the drug itself is subsidised (PBS co-payment). There is a consultation and procedure fee for the injection appointment, which attracts a Medicare rebate. A detailed quote is provided at booking. Treatments outside PBS criteria require private payment for the medication, which is significantly more expensive.
How long until I know if it's working? +
Response is assessed after the second cycle (around 24 weeks from starting). PBS continuation requires a documented reduction of at least 50% in headache days. Some patients respond after cycle 1; others need three cycles to reach full effect.
Important: This page is general health information for adults living in Australia and is not a substitute for individual medical advice. Botox for chronic migraine has specific PBS eligibility criteria and is prescribed only after a comprehensive consultation. Treatment decisions are made on an individual basis with your treating doctor.

Considering Botox for Your Migraines?

Book a consultation with Dr Ron Granot — accredited Botox injector and headache specialist neurologist in Bondi Junction.

Book a Consultation

Book Your Appointment Today

Stop waiting years for answers. Fill out the form below and we'll contact you to schedule your appointment.

.